<DOC>
	<DOCNO>NCT02938078</DOCNO>
	<brief_summary>The primary study objective : evaluate ( 1 ) change ocular discomfort 30 day ( 2 ) change sign symptom ocular surface disease demodex-positive subject begin use Avenova .</brief_summary>
	<brief_title>Ocular Comfort Inflammation Lid Hygiene Therapy</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Blepharitis</mesh_term>
	<criteria>Subject sign date IRBapproved informed consent document Mild great Demodex ( minimum 15 observable mite six lash ) Score 20 OSDI Questionnaire Score 20 Eyelid Inflammation Questionnaire Currently enrol another prospective research study Unable attend two followup visit 30 day Current allergic conjunctivitis cornea , conjunctiva , eyelid either eye Prior ocular trauma surgery indicate Prior corneal transplant either eye Any ocular surgery within past six month Abnormal corneal scarring , erosion , StevensJohnson syndrome Anticipation ocular surgery within next 30 day NonEnglish speaking Pregnant , nursing , expect become pregnant within next 30 day Known sensitivity chlorine Avenova Moderate , severe conjunctivochalasis Contact lenses within last 30 day unwilling discontinue 30 day Use topical cyclosporine le 6 continuous month prior baseline Procedure pulse light commercial lid massage last 30 day Known history autoimmune disease Punctal plug place within last 30 day Use Avenova lid cleanser within last 30 day Changes systemic ocular medication last 30 day Unwilling commit ocular systemic medication 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>